TTY Biopharm Co Ltd Capital Reinvestment Ratio
TTY Biopharm Co Ltd capital reinvestment ratio. TTY Biopharm Co Ltd (4105) has a Capital Reinvestment Ratio of 0.20x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$654.16 Million) in capital expenditures (NT$128.28 Million). Check total reinvestment intensity of TTY Biopharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of TTY Biopharm Co Ltd (2017–2025)
Capital reinvestment ratio of TTY Biopharm Co Ltd from 2017 to 2025. This chart tracks TTY Biopharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore 4105 net asset momentum to track the company's year-over-year net asset growth rate.
TTY Biopharm Co Ltd Capital Reinvestment Ratio by Year (2017–2025)
TTY Biopharm Co Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see 4105 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | NT$1.76 Billion | NT$150.83 Million | ▼ -14.0% |
| 2024 | 0.10x | NT$1.35 Billion | NT$134.29 Million | ▲ +8.5% |
| 2023 | 0.09x | NT$1.09 Billion | NT$99.58 Million | ▼ -16.3% |
| 2022 | 0.11x | NT$1.24 Billion | NT$135.50 Million | ▲ +85.8% |
| 2021 | 0.06x | NT$1.26 Billion | NT$74.15 Million | ▼ -82.9% |
| 2020 | 0.35x | NT$526.35 Million | NT$181.86 Million | ▲ +498.3% |
| 2019 | 0.06x | NT$1.21 Billion | NT$69.86 Million | ▼ -16.3% |
| 2018 | 0.07x | NT$1.07 Billion | NT$74.09 Million | ▼ -29.0% |
| 2017 | 0.10x | NT$996.52 Million | NT$96.79 Million | — |